Amphivena Therapeutics, Inc.
Biotechnology company · South San Francisco, California, United States
Amphivena Therapeutics, Inc. is a biotechnology company headquartered in South San Francisco, California, United States. Its earliest recorded incorporation is in 2012. It has reported private securities offerings to the US SEC, most recently $39 million sold in a notice filed in 2018.
Amphivena Therapeutics at a glance
What does Amphivena Therapeutics do?
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $38.7 million sold (2018).
Frequently asked questions about Amphivena Therapeutics
Where is Amphivena Therapeutics headquartered?
Amphivena Therapeutics, Inc. is headquartered in South San Francisco, California, United States.
What does Amphivena Therapeutics do?
Amphivena Therapeutics, Inc. is a biotechnology company.
When was Amphivena Therapeutics founded?
The earliest incorporation on record for Amphivena Therapeutics, Inc. is in 2012, according to public company registers.
Similar companies
- Alector, Inc.South San Francisco, California, United States
- Vaxart, Inc.South San Francisco, California, United States
- Denali Therapeutics Inc.South San Francisco, California, United States
- Aligos Therapeutics, Inc.South San Francisco, California, United States
- PROFUSA, Inc.South San Francisco, California, United States
- Quince Therapeutics, Inc.South San Francisco, California, United States
- Allogene Therapeutics, Inc.South San Francisco, California, United States
- Sutro Biopharma, Inc.South San Francisco, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences